Keep track of such patients for signs of sedation and respiratory despair, specially when initiating therapy with oxycodone and acetaminophen tablets.After stopping a CYP3A4 inducer, given that the effects with the inducer decrease, the oxycodone plasma focus will raise [see CLINICAL PHARMACOLOGY], which could maximize or prolong both equally the t